{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_15", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "trolled \nstudies of [TRADENAME] in pregnant women. When treating pregnant \nwomen with [TRADENAME], carefully consider whether the potential \nbenefits outweigh the potential risks of treatment. \n \nNo teratogenic effects were observed when [drugname] was given to \npregnant rats or rabbits during the period of organogenesis at oral doses \nup to 200 and 36 mg/kg/day, respectively. These doses are 48 and 17 \ntimes, in rats and rabbits, respectively, the maximum recommended \nhuman dose (MRHD) of 40 mg"}